Open access

Ligand-Induced Cell Adhesion in Synapse Formation

Written By

Fernanda Ledda

Published: 10 October 2012

DOI: 10.5772/50106

From the Edited Volume

Cell Interaction

Edited by Sivakumar Gowder

Chapter metrics overview

2,726 Chapter Downloads

View Full Metrics

1. Introduction

Construction of the neural netwoks depends largely on precise contacts between neurons and non-neuronal cells. Numerous studies have described different types of adhesive interactions between cells in the nervous system. These include adhesive contacts between neural cell bodies, axonal attachments to glial cells, axon fasciculation, connection between pre- and postsynaptic specializations as well as to cells outside the nervous system. Although some of the molecules that mediate each of these types of neural adhesive contacts have been characterized, some remain unknown.

Neuronal synapses can be considered as a specialized type of cell-cell interaction that mediates communication between neurons and their target cells. It involves the interaction between two asymmetric partners, the presynaptic specialization, where the synaptic vesicles release neurotransmitters and the postsynaptic density, which contains receptors and adapter scaffold proteins that transduce the neurotransmitter signal [1].As at other cell-cell junctions, such as epithelial tight junctions or the immune synapse, synaptically-localized neural cell adhesion molecules are not merely static structural components but are often dynamic regulators of synapse function.

In the last years numerous studies provide new insights into the role of adhesion molecules in the formation, maturation, maintenance, function and plasticity of synaptic contacts. Several cell adhesion molecules have been involved in synapse development, including, cadherins, proteocadherins, integrins, NCAM, L1, Fasciclina, Syg, Sidekicks, SynCam, Neurexin-Neuroligin, LRRTM, GDNF/GFR, Neurexin/Cbl1/GluR2, between others [2].Trans-synaptic cell adhesion molecules are particularly attractive candidate mediators of synapse formation because of their potential to bidirectionally coordinate functional and morphological synapse differentiation [3,4].

During neuronal development, specific synaptic circuits are generated by synapse formation between the appropriate pre- and postsynaptic partners and aberrant connectivity can lead to nervous system disorders. The accuracy of synapse formation is fundamental for the normal brain development and depends in part on the controlled spatial and temporal expression of selective adhesion molecules on neuronal surface.


2. Adhesion at the synapses

Many cell adhesion molecules are localized at synaptic sites in neuronal axons and dendrites. These molecules bridge pre- and postsynaptic specializations but do far more than simply provide a mechanical link between cells, they are important elements in the trans-cellular communication mediated by synapses. During the last years, some adhesion complexes, which are involved in the formation, maintenance and modulation of synaptic contacts, have emerged. Three particularly interesting molecular systems of pre- and postsynaptic partners that interact in trans across the synaptic cleft, have been described: Neurexin-Neuroligin, LRRTM and SynCam.

2.1. Neurexins and neuroligins

Neurexins (Nrxns) and Neuroligins (Nlgns) are the best characterized synaptic cell adhesion system.Neurexins were originally discovered as receptors for -latrotoxin, a vertebrate-specific toxin present in the black widow spider venom that binds to presynaptic receptors and induces massive neurotransmitter release [5]. There are two types of Nrxns, a longer -Nrxn (-Nrxn and a shorter -Nrnx (-Nrxn isoforms. While -Nrxn have six extracellular LNS domains (Laminin/ Neurexin/ Sex hormone-binding globulin-domain) with three intercalated EGF-like domains, -Nrxn only contains a single LNS domain [6,7,8]. Immunofluorescence and subcellular fractionation analysis indicate that Nrxns are located on presynaptic terminals [6,9].

Mammals contain three Nrxn genes (Nrxn1-3), each of which directs the transcription of - and -Nrxns from independent promoters [10]. Neurexins are evolutionary conserved and pan-neuronally expressed [10,11]. Homologues of neurexin genes have been described in low vertebrates such as Danio rerio [12], and invertebrates such as Drosophila melanogaster, Caenorhabditis elegans, honeybees and Aplysia [10,13,14,15]. In mammals, alternative splicing of Nrxns can generate thousands of alternatively spliced mRNA transcripts. The ectodomain of -Nrxns contains five sequences that can be alternatively spliced (S1-5), two of which are also present in -Nrxns (S4 and S5) [10,11]. Some of these splice sites are localized in the Nrxn binding domain. Interestingly, Nrxn alternative splicing is regionally regulated during development and by neural activity [11,16], and plays an important role in modulating its function at synapses. Indeed, Nrxn distribution to excitatory and inhibitory synapses seems to be regulated by alternative splicing. It has been reported that -Nrxn without the S4 sequence (-S4) induce differentiation of excitatory synapses while -Nrxn containing the S4 insert (+S4) promote differentiation of inhibitory synapses [17,18]. Furthermore, -Nrxn also strongly promotes differentiation of inhibitory synapses [17].

Neuroligins have been identified as endogenous Nrxns ligands [19,20]. As Nrxns, Neuroligins (Nlgns) are type I membrane proteins that consist of an extracellular region, involved in trans-synaptic interactions, a single transmembrane sequence and a small cytoplasmic domain that contain a PDZ-domain binding sequence that recruits PSD-95 and other PDZ-domain proteins [21]. The extracellular region contains a domain homologous to acetylcholinesterase, without its enzymatic activity. All Nlgns are enriched in postsynaptic densities. The human genome expresses five Nlgns isoforms (Nlg1-5), and rodent genome contains only 4 isoforms (Nlg1-4).Homologues of Nlgns have been identified in invertebrates including Drosophila melanogaster [22,23], honeybees [13,24], Caenorhabditiselegans [25] and Aplysia [14,15]. In mammals, Nlgns contains two alternative splice sites referred to as SA (in Nlgn1-3) and SB (in Nlgn-1) [20,26]. In contrast to Nrxns, Nlgns are specifically localized to particular synapses. Several studies revealed that Nlgn1 and Nlgn2 are exclusively localized to excitatory and inhibitory synapses respectively. Nlgn3 has been described to be present at both inhibitory and excitatory synapses in hippocampal cells [27,28,29,30,31], while Nlgn4 appears to be localized to inhibitory synapses in some tissues such as, retina, spinal cord, and several lower brain regions; and to excitatory synapses in some tissues such as, hippocampus and cortex [27].

Nrxn-Nlgn complex has been involved in the formation, maturation and function of vertebrate synapses. The evidence indicates that Nrxn-Nlgn bind each other by their extracellular domain to promote adhesion between pre- and postsynaptic specializations, recruiting pre- and postsynaptic molecules to form a functional synapse. Cell based assays of synapse assembly showed that contact of dissociated neurons with Nlgn-expressing fibroblasts can induce the formation of functional presynaptic specializations by recruiting components of the presynaptic machinery in co-cultured neurons [32], while contact of neurons with Nrxn expressing non-neuronal cells can induce postsynaptic differentiation and clustering of postsynaptic receptors in contacting dendrites [31,33].

Recent studies indicate that alternative splicing of Nrxn and Nlgn mRNA may play an important role modulating the assembly and synapse properties of Nrxn-Nlgn complex [26]. As it has been previously mentioned, Nrxns and Nlgns contain sequences that can be alternatively spliced. Some of these splice sites are localized in the Nrxn-Nlgn binding interface, placing them in a relevant position to modulate Nrxn-Nlgn engagement.It has been proposed that alternative splicing of Nrxns underlies an adhesive code and/or synapse-specific functions [18,34,35]. The evidence indicates that the sequence S4 of Nrxn and insert B of Nlgn have a crucial role in the Nrxn-Nlgn interactions. It has been described that the presence of the insert S4 in -Nrxn (+S4) strongly reduces binding to Nlgn1 containing the insert B (+B) [26], indicating that Nlgn1(+B), the most common form of Nlgn1, interacts preferentially with -Nrxn (-S4). Moreover, the presence of insert B inhibits the binding of Nlgn1 to -Nrxns [36]. On the other hand, the alternative splicing of the segment S4 in Nrxn controls interactions with other Nrxn ligands, such as leucine-rich repeat proteins (LRRTMs) and the Cbln1-GluR2 complex (See bellow).

The trans-synaptic Nrxn-Nlgn complex promotes the assembly and maturation of pre-and postsynaptic machinery. Although the presynaptic signaling events induced by Nrxns are currently not clear, the evidence indicates that neurexins bind directly to the presynaptic scaffolding proteins CASK, MINT1 and to protein 4.1; and could therefore recruit elements of the presynaptic release machinary [37,38]. In agreement with this, it has been shown that RNA interference (RNAi)-mediated supression of the Nlgn-1, -2, -3 in neuronal cultures reduces the number of excitatory and inhibitory synapses [18]. Conversely, Nlgn1 overexpression in neurons has been found to increase the formation of mature presynaptic boutons, enhace the size of the pool of recycling synaptic vesicles and the rate of synaptic vesicle endocytosis [39,40]. Regarding to the postsynaptic consequences of Nrxn-Nlgn interaction, it was described that in excitatory synapses, this adhesion complex is able to capture AMPA receptors through PSD-95 scaffolding proteins [41]. NMDARs are also recruited to Nrxn-Nlgn complex, but this recruitment does not depend on the presence of PSD-95 [42]. On the other hand, studies on Nrxn-Nlgn interaction at inhibitory synapses indicates that the contact between -Nrxn and Nlgn2 induces clustering of Nlgn2 and recruitment of the post-synaptic scaffolding protein Gephyrin to inhibitory synapses [31]. Complex formation between Nlgn2, Geophyrin and a brain specific GDP/GTP exchange factor, Collybistin, recruits GABA and Glycine receptors to nascent inhibitory synapses. Interestingly, deletion of Nlgn2 in mice perturbs GABAergic and glicinergic synaptic transmission and leads to a loss of postsynaptic specializations specifically at inhibitory synapses [43].

Although the in vitro evidence indicates that Nrxn-Nlgn complex induces synapse formation, the analysis of different Nlgn and Nrxn knockout mice are controversial. In vivo deletion of all Nrxn or of Nlgn1-3 do not substantially affect synapse formation [30,44], but impair synapse function, suggesting that -Nrxn and Nlgns are cell adhesion molecules that play an essential role in synapse maturation but are not essential for synapse formation.

2.2. LRRTM

The LRRTM gene family was first described in 2003 [45]. The LRRTM family has four members (LRRTM 1-4) that share similar domain structure with an extracellular domain containing ten extracellular leucine-rich repeats that mediate protein-protein interactions, followed by a single transmembrane domain and a short c-terminal sequence containing a class I PDZ-domain-binding motif. Human and mouse LRRTMs are highly conserved and orthologous genes exist in other vertebrates, but not in invertebrates [45].

In situ hybridization, RT-PCR and immunofluorescence analysis showed that LRRTMs are predominantely expressed in the nervous system and that each LRRTM present a specific and partially overlapping expression pattern [45,46,47]. The four LRRTM are expressed in neurons of the hippocampus, cerebral cortex and in the striatum.LRRTM1 and LRRTM2 are also highly expressed in the thalamus. In contrast, neither LRRTM3 nor LRRTM4 are expressed in these structures. The structural similarities and expression patterns of LRRTMs indicates a possible functional redundancy between them [45].

All four LRRTMs family members are post-synaptic localized and when expressed in non-neuronal cells co-cultured with hippocampal neurons they can induce presynaptic differentiation in contacting axons. LRRTM1 and LRRTM2 selectively promote excitatory, but not inhibitory presynaptic differentiation [46]. In addition, Wit et al (2009) demonstrated that LRRTM2 can interact with the post-synaptic protein PSD-95 and regulate surface expression of AMPA receptors [48].

Independent studies have shown that post-synaptic LRRTM1 and LRRTM2 bind specifically to presynaptic and -Nrxn lacking an insert at S4 [49]. Thus, whereas Nlgns bind Nrxn containing or lacking an insert in splice site S4, LRRTMs bind only Nrxns lacking an insert in this splicing site [48,50]. This ability to regulate interaction Nrxn-Nlgn and Nrxn-LRRTM provides an intringuing mechanism for regulating synaptic specificity.

Consistent with the effects of LRRTM on neuronal connectivity, deletion of LRRTM1 in mice revealed altered distribution of the vesicular glutamate transporter vGlut1 in vivo [46]. Furthermore, it was demonstrated that lentivirus-mediated knockdown of LRRTM2 in vivo decreases the strength of glutamatergic synaptic transmission. Conversely, LRRTM2 overexpression resulted in an increase of excitatory synapses [48,51].

2.3. SynCAM

The SynCAM (Synaptic Cell Adhesion Molecule) family comprises four genes encoding proteins (SynCAM1-4) with three inmuonoglobulin (Ig)-like domains, a single transmembrane region, and a short cytosolic tail with a PDZ type II motif. SynCAM proteins are predominantly expressed in the brain and localize to pre- and postsynaptic sites [52,53].

All SynCAMs are expressed mostly by neurons during the peak period of synaptogenesis around the second postnatal week and remains expressed throughout adulthood in the hippocampus [52].

SynCAM proteins are present at presynaptic and postsynaptic specializations and are involved in homophilic and heterophilic interactions via the extracellular (Ig)-like domains. Interestingly, SynCAM1, 2 and 3, but not SynCAM4, can associate in trans by homophilic interactions. However, the evidence indicates stronger heterophilic interactions of SynCAM1/2 and SynCAM3/4 more than homophilic adhesion between each other [54]. It has been shown that heterophilic adhesion complex of SynCAM1/2 drives presynaptic terminal formation in cultured neurons, increasing the number of excitatory synapses [54]. In agreement with a functional role of SynCAM1 in neuronal connectivity, it has been demonstrated that elevated expression of SynCAM in a transgenic model increases functional excitatory synapse number [55]. Conversely, SynCAM1 knockout mice exhibited fewer excitatory synapses. Interestingly, SynCAM1 can alter the plasticity of synapses once they are formed. Thus, SynCAM1 overexpression has been shown to abrogate long term depression (LTD), while it loss increased LTD [55].


3. Control of synapse formation by ligand-induced cell adhesion molecules (LICAM)

During the last years, a novel mechanism of ligand-induced cell adhesion has been described. Unlike other cell adhesion systems, which involve the simple encounter of membrane associated cell adhesion molecules in trans, ligand-induced cell adhesion is mediated by membrane-associated proteins but is dependent on the presence of its soluble ligand. This feature may allow a more dynamic response to external stimulus involved in synapse development.

3.1. GDNF and GFR1

The Glial cell-line Derived Neurotrophic Factor (GDNF) and its glycosylphosphatidylinositol (GPI)-anchor receptor, GFR1, represent the first example of this new mechanism of cell-adhesion [56]. In this system, GDNF, is able to mediate trans-homphilic cell adhesion between cells expressing its receptor, GFR1. The receptor involved in this process, the GFR1, can be considered as a ligand-induced cell adhesion molecule (LICAM). The molecular bases underlying trans-homphilic interaction mediated by GDNF and GFR1 is not clear yet. The domains of GFR1 underlying its LICAM activity have been analyzed using deletion mutants of the receptor. This study revealed that the GFR1-mediated cell adhesion requires the presence of an intact ligand-binding domain in both interacting partners. In principle, GDNF, as a dimeric protein could promote trans-homophilic interactions between receptor-expressing cells. On the other hand, GDNF could act through an allosteric mechanism.

During the last years, numerous studies have shown that GDNF-family ligands contribute to synapse development and maturation [57,58]. The developmental expression pattern of GFR1 and its ligand, GDNF, during the period of hippocampal synaptogenesis as well as its subcellular localization at pre- and postsynaptic specializations indicated a possible role of GDNF-GFR1 complex in the formation of neuronal synapses by inducing trans-synaptic homophilic cell adhesion. Indeed, microspheres containing GFR1, mimicking its postsynaptic localization, were able to induce presynaptic differentiation on hippocampal and cortical neurons cultured in the presence of GDNF. This effect was evidenced by recruitment of vesicle-associated synaptic protein, neurotransmitter transporters and activity-dependent vesicle recycling on the hippocampal axons at the sites of contact [56]. Intringuinly, the presynaptic maturation triggered by GDNF and GFR1 was independent of the canonical receptor Ret and only partially dependent on the neural cell adhesion molecule, NCAM, indicating the existence of an additional signaling molecule involved in this process (Figure 1A)[56,57,59,60]. Whether postsynaptically localized GFR1 may contribute to postsynaptic maturation remains to be explored. Thus, the ability of GDNF to trigger trans-homophilic interactions between GFR1 molecules represents the first example of regulated cell-cell interactions and a new synaptogenic mechanisms that combines soluble and membrane bound molecules by inducing conformational changes that reorient and expose determinants involved in trans-homphilic binding [56,57].

3.2. Cerebelin-GluR-neurexin

More recently another example of ligand-induced trans-synaptic adhesion interaction has been described.Uemura et al (2010) described that the postsynaptic glutamate receptor(GluR)2 interacts with the presynaptic -Nrnx through the presynaptically secreted glycoprotein, Cerebelin 1 precursor protein (Cbln1) [61].

Based on its amino acid sequence, GluR2, is a member of the ionotrophic glutamate receptor family, which plays an essential role in cerebellar Purkinje cells (PC) synapse formation [61,62]. The synaptogenic activity induced by GluR2 can be reproduced in vitro using primary cultures of cerebellar granule cells (GC) and the extracellular N-terminal domain of GluR2 [61] indicating that this domain is critical for its synaptogenic activity. Binding studies demonstrated that postsynaptic GluR2 interacts with presynaptic Nrxns, which are known to play a crucial role in presynaptic organization. But this interaction is established through the presynaptically secreted glycoprotein Cbln1. Interestingly, the synaptogenic activity of GluR2 is abolished in cerebellar primary cultures from Cbln1 knockout mice and is restored by recombinant Cbln1. In agreement with this, Cbln1-null mice show similar behavioral and physiological phenotypes to those of GluR2-null mice confirming that Cbln1 and GluR2 are involved in a similar signaling pathway [63]. Direct binding experiments demonstrated that Cbln1 acts as a divalent ligand for postsynaptic GluR2 and presynaptic Nrxns, representing a new example of ligand induced trans-heterophylic synaptic adhesion. The resulting complex, Nrxn/Cbl1/GluR2, mediates synapse formation between cerebellar granule cells and Purkinje cells (Figure 1B). In accordance with this, the amino terminal domain of GluR2 and the extracellular domain of -Nrxn1 suppressed the synaptogenic activity of Cbln1 in cerebellar primary cultures in vivo indicating that the interaction of GluR2, Cbln1 and Nrxn is essential for cerebellar synapse formation [61].

The evidence indicates that Cbln1 interacts with different subtypes of -Nrxn and -Nrxn containing the S4 insert, but not to subtypes lacking the S4 insert, to induce synaptogenesis in cultured cerebellar, hippocampal and cortical neurons. Interestingly, -Nrxn containing the S4 insert binds to Cbln1 [62] but does not bind to any Nlgs or LRRTMs. Another distinctive feature of the Nrxn/Cbln1/GluR2 complex is that it is insensitive to the extracellular Ca2+ concentration [62]; while binding of Nrxn to Nlgs and LRRTMs requires extracellular Ca2+.

While GluR2 is mainly expressed in cerebellar Purkinje cells, GluR1 is widely expressed in the developing forebrain including the caudate putamen and hippocampus. In a recent study it has been demonstrated that, in the presence of Cbln1 or Cbln2, GluR1 expressed in non-neuronal cells can induce inhibitory presynaptic differentiation on cultured cortical neurons by interacting with Nrxns containing the S4 insert [64].


4. Transient cell-cell interactions in neural development

Trans-synaptic adhesion molecules can affect the function of synapses at multiple levels, from recruiting synaptic proteins during synaptogenesis to regulating synaptic plasticity [1]. Thus, adhesion molecules are involved in dynamic processes such as synapse formation, which involves cell-type specific target recognition and synaptic plasticity, which requires the response to external stimulus or perturbations. A delicate balance between adhesion and de-adhesion cooperates generating robustness and flexibility to ensure normal nervous system development.

Figure 1.

Model describing ligand-induced trans-synaptic cell adhesion induced by (A) GDNF and (B) Cerebelin1.

The majority of trans-synaptic adhesion mechanisms known to date involve interactions triggered by the encounter between cell adhesion molecules inserted in the pre- and postsynaptic compartments. The activity of these cell-adhesion molecules may be regulated either developmentally or in response to neuronal activity. For instance, activity- dependent alternative splicing of Nrxn transcripts, or post-translational modifications such as glycosilation, polysialilation or palmitoylation drastically modify adhesive properties; binding partners and signaling properties of certain adhesion molecules [26,65,66]. Ligand-induced cell adhesion represents a previously unknown mechanism in which cell adhesion can be regulated not only by the presence of different forms of the associated receptor but also by ligand availability [56]. Furthermore, ligand secretion could also be regulated, for example by neuronal activity. Thus, trans-homophilic binding between GFR1 molecules might be controled by the activity-dependent upregulation of GDNF, which has been shown to be upregulated by seizure activity [67,68]. On the other hand trans-heterophilic binding between GluR2 and Nrxn might also be regulated by the availability of Cbln1. It has been described that the expression of Cbln1 mRNA is completely shut down in mature granule cells when the neuronal activity is increased by kainate [69]. Moreover, a recent study revealed that the-ligand binding domain of GluR2 can also bind to D-Ser inducing conformational changes of the receptor that might modify the synaptogenic activity of the Nrnx/Cbl1/GluR2 complex [70,71]In addition, D-Ser has been shown to be regulated during development and also to be release from astrocytes in an activity-dependent manner [71]. Thus, the activity dependent regulation of each component of the Nrnx/Cbl1/GluR2 might increase the plasticity of the system.

Ligand-induced cell adhesion represents a new way to regulate intercellular interactions that may have broad implications not only for the development of the nervous system, but also in other tissues and organs.


5. Role of synaptic cell adhesion systems in nervous system disorders

The ability of trans-synaptic cell adhesion molecules to regulate synapse formation, maturation and plasticity supports the idea that deficits in many synaptogenic genes might be associated to neurodevelopmental and/or neuropsychiatric diseases.

Numerous studies indicate a genetic link of mutations in synaptic cell adhesion molecules to autism-spectrum disorders (ASD), in particular to Nlgs and Nrxns [72,73]. Mutations in genes encoding Nrxn1, Nlg3 and Nlg4 have been described to be associated with ASD. These alterations include different type of mutations that have been observed in a small fraction of patients. In particular thirteen different mutations have been described in Nrxn1 gene: seven point mutations, two distinct translocations and four different deletions [72,74,75,76,77,78,79]; ten different mutations has been found in Nlg4 gene: two frameshifts, five missense mutations and three internal deletions; and a single mutation in Nlg3 gene (R451C) [72,80,81,82,83]. Moreover, deletions in X-chromosome that includes the Nlg4 locus were detected in patients with autism [79,84,85,86]. Different studies have reported that Nlg4 deletions are also associated with other neurological disturbances including Tourette syndrome, attention deficit hyperactivity disorders, anxiety and depression. In addition, two different deletions of -Nrxn1 have been observed in families with schizophrenia [58,87,88].

The role of some of these proteins in ASD has been validated in trasgenic animals. Thus, the Nlg3-R451C knockin mouse were reported to show a phenotype that shares some, but not all features with human ASD patients These mice show a modest impairment in social behaviour [89]. Moreover, Nlg-4 knockout mice show deficits in social interactions and communication [90].

In addition, members of SynCAM and LRRTM families have also been associated with nervous system disorders. SynCAM1 has been associated with ASD. Two missense mutations in the SynCAM1 gene of ASD patients and their families have been described.Interestingly, the mutations were located in one domain, which is essential for trans-synaptic interaction [91]. In a recent genetic study, polymorphisms in LRRTM3 were associated with ASD [88]. Moreover, LRRTM1 has been associated with schizophrenia [92].

There is no strong evidence connecting mutations in genes involved in ligand-induced cell adhesion systems with nervous system diseases. So far, only GluR1 was found to be associated with schizophrenia [92,93].

Further studies linking mutations in cell adhesion systems with nervous system diseases will contribute to the design of new diagnostic and therapeutic tools for these disorders.


6. Perspectives

It is well established, that cell-adhesion systems are in part responsible for the construction of neural circuits, synapse formation and plasticity. The correct function of the nervous system depends on the establishment of precise synaptic contacts between neurons and its specific targets, and deficits in genes coding for trans-adhesion molecules have been associated with learning deficits and cognitive impairments.

During the last years several adhesion molecules have been reported to participate in synapse development, including integrins, cadherins, protocadherins, NCAM, Neurexin-Neuroligin, LRRTM, SynCam, GDNF/GFR, Nrxn-Cbl1-GluR2. The discovery of alternative trans-synaptic binding partners, in combination with their differential splice variants and isoforms, gave rise to a much larger spectrum of trans-synaptic interactions than was originally though. Furthermore, the mechanism of ligand induced cell adhesion considerably expands the functional repertoire of the ligands and receptors involved in these adhesion complexes and represents a new way to regulate trans-synaptic interactions that may have broad implications for the development of the vertebrate nervous system. Regulation of adhesion by soluble ligands allows a dynamic synaptic response to external stimulus during synapse formation and synaptic plasticity.

Based on this, the main challenge will be now to elucidate the complex code by which the trans-synaptic cell adhesion systems participate in the different steps of synapse formation, maturation and plasticity and to understand the importance of the different combinations of trans-synaptic partners in specific circuits. It will be important to understand how the combination of multiple synaptogenic systems may contribute to synaptic specificity controlling exactly where and when synapses form.

It will be also necessary to address whether individual synapse organizing protein instruct synaptic cell adhesion, or if the trans-synaptic interaction results from cooperation among different adhesion molecules. In some cases it is likely that the determination of initial synapse formation is mediated by multiple adhesion systems acting in parallel, as has been evidenced by α-Nrxs and Nlgns knockout mice. The analysis of these animals showed that knockdown of these molecules, does not have consequence in synapse formation, suggesting that other adhesions systems compensate the deficiency in these mice [30,44].

The fact that multiple partners function at the same synapses opens the possibility that they cooperate in the recruitment of the same components to the synapse. Indeed, it has been described that overexpression of Nlgns and LRRTMs in primary hippocampal neurons cooperate in a synergistic manner in glutamate synapse development visualized by an increase in the recruitment of pre-synaptic proteins. Cooperation between different adhesion systems may help to stabilize interactions across the cleft by recruiting the pre- and postsynaptic machinery at multiple points. However the existence of mechanisms that can modulate and modify these interactions should be important, especially for synaptic plasticity.

Further understanding of the molecular pathways and circuit events downstream these cell adhesion organizing systems will be extremely important in light of the role of trans-synaptic cell adhesion molecules in neurodevelopmental and cognitive diseases.


  1. 1. Scheiffele 2003 Cell-cell signaling during synapse formation in the CNS. Annu Rev Neurosci 26: 485-508.
  2. 2. YamagataM.SanesJ. R.WeinerJ. A. 2003 Synaptic adhesion molecules. Curr Opin Cell Biol 15 621632 .
  3. 3. MisslerM.SudhofT. C.BiedererT.(201Synapticcell.adhesion Cold Spring Harb Perspect Biol 4
  4. 4. KruegerD. D.TuffyL. P.PapadopoulosT.Brose 2012 (2012) The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr Opin Neurobiol.
  5. 5. UshkaryovY. A.RohouA.Sugita 2008ugita S (2008) alpha-Latrotoxin and its receptors. Handb Exp Pharmacol: 171206 .
  6. 6. UshkaryovY. A.PetrenkoA. G.GeppertM.SudhofT. C. 1992 Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 257 5056 .
  7. 7. Ushkaryov YA, Sudhof TC 1993 Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms. Proc Natl Acad Sci U S A 90 64106414 .
  8. 8. UshkaryovY. al. 1994 Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins. J Biol Chem 269 1198711992 .
  9. 9. BerninghausenO.MARahmanSilva. J. al. 2007 Neurexin Ibeta and neuroligin are localized on opposite membranes in mature central synapses. J Neurochem 103 18551863 .
  10. 10. TabuchiK.SudhofT. C. 2002 Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 79 849859 .
  11. 11. UllrichB.UshkaryovY. A.SudhofT. C. 1995 Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 14 497507 .
  12. 12. al. 2007 Comparative genome analysis of the neurexin gene family in Danio rerio: insights into their functions and evolution. Mol Biol Evol 24 236252 .
  13. 13. BiswasS.RussellR. J.JacksonC. al. 2008 Bridging the synaptic gap: neuroligins and neurexin I in Apis mellifera. PLoS One 3: e3542.
  14. 14. ChoiY. B.LiH. L.KassabovS. R.JinI.PuthanveettilS. al. 2011 Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron 70 468481 .
  15. 15. KnightD.XieW.BoulianneG. L.Neurexinsneuroliginsrecent.insightsfrom.invertebrates Mol Neurobiol 44 426440 426440
  16. 16. Rozic-KotliroffG.Zisapel 2007 (2007) Ca2+-dependent splicing of neurexin IIalpha. Biochem Biophys Res Commun 352 226230 .
  17. 17. KangY.ZhangX.DobieF.WuH.CraigA. M. 2008 Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J Biol Chem 283 23232334 .
  18. 18. ChihB.GollanL.Scheiffele 2006 Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 51: 171-178.
  19. 19. al. 1995 Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 81 435443 .
  20. 20. IchtchenkoK.NguyenT.SudhofT. C. 1996 Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 271 26762682 .
  21. 21. al. 1997 Binding of neuroligins to PSD-95. Science 277 15111515 .
  22. 22. al. 2011 Neuroligin 2 is required for synapse development and function at the Drosophila neuromuscular junction. J Neurosci 31 687699 .
  23. 23. al. 2010 Drosophila neuroligin 1 promotes growth and postsynaptic differentiation at glutamatergic neuromuscular junctions. Neuron 66 724738 .
  24. 24. BiswasS.ReinhardJ.OakeshottJ.RussellR.SrinivasanM. al. 2010 Sensory regulation of neuroligins and neurexin I in the honeybee brain. PLoS One 5: e9133.
  25. 25. HunterJ. W.MullenG. P.Mc ManusJ. R.HeatherlyJ. al. 2010 Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech 3 366376 .
  26. 26. AABoucardChubykin.AAComolettiD.TaylorP.SudhofT. C. 2005 A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48 229236 .
  27. 27. al. 2011 Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. Proc Natl Acad Sci U S A 108 30533058 .
  28. 28. Budreck EC, Scheiffele 2007 Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur J Neurosci 26: 1738-1748.
  29. 29. SongJ. Y.IchtchenkoK.SudhofT. C.Brose 1999 (1999) Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci U S A 96 11001105 .
  30. 30. VaroqueauxF.JamainS.Brose 2004 (2004) Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 83 449456 .
  31. 31. GrafE. R.ZhangX.JinS. X.LinhoffM. W.CraigA. M. 2004 Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119 10131026 .
  32. 32. ScheiffeleP.FanJ.ChoihJ.FetterR.Serafini 2000 (2000) Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 657669 .
  33. 33. Nam CI, Chen 2005 (2005) Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc Natl Acad Sci U S A 102 61376142 .
  34. 34. Craig AM, Kang 2007 (2007) Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 17 4352 .
  35. 35. Huang ZJ, Scheiffele 2008 GABA and neuroligin signaling: linking synaptic activity and adhesion in inhibitory synapse development. Curr Opin Neurobiol 18: 77-83.
  36. 36. TanakaH.NogiT.YasuiN.IwasakiK.Takagi 2011 (2011) Structural basis for variant-specific neuroligin-binding by alpha-neurexin. PLoS One 6: e19411.
  37. 37. BiedererT.SudhofT. C. 2001 CASK and protein 4.1 support F-actin nucleation on neurexins. J Biol Chem 276 4786947876 .
  38. 38. HataY.ButzS.SudhofT. C. 1996 CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci 16 24882494 .
  39. 39. LevinsonJ. N.LiR.KangR.MoukhlesH.El al. 2010 Postsynaptic scaffolding molecules modulate the localization of neuroligins. Neuroscience 165 782793 .
  40. 40. al. 2009 Postsynaptic Neuroligin1 regulates presynaptic maturation. Proc Natl Acad Sci U S A 106 1356413569 .
  41. 41. al. 2011 Neurexin-neuroligin adhesions capture surface-diffusing AMPA receptors through PSD-95 scaffolds. J Neurosci 31 1350013515 .
  42. 42. BarrowS. L.ConstableJ. R.ClarkE.El -SabeawyF.Mc AllisterA. al. 2009 Neuroligin1: a cell adhesion molecule that recruits PSD-95 and NMDA receptors by distinct mechanisms during synaptogenesis. Neural Dev 4: 17.
  43. 43. al. 2009 Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 63 628642 .
  44. 44. MisslerM.ZhangW.RohlmannA.KattenstrothG.HammerR. al. 2003 Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423 939948 .
  45. 45. LaurenJ.MSAiraksinenSaarma. M.Timmusk 2003immusk T (2003) A novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous system. Genomics 81 411421 .
  46. 46. LinhoffM. W.LaurenJ.CassidyR. M.DobieF. al. 2009 An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61 734749 .
  47. 47. Haines BP, Rigby PW 2007 Developmentally regulated expression of the LRRTM gene family during mid-gestation mouse embryogenesis. Gene Expr Patterns 7 2329 .
  48. 48. de WitJ.SylwestrakE.O’SullivanM. al. 2009 LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 64 799806 .
  49. 49. SiddiquiT. J.PancarogluR.KangY.RooyakkersA.CraigA. M. 2010 LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 30 74957506 .
  50. 50. KoJ.ZhangC.AracD.AABoucardBrunger. A. al. 2009 Neuroligin-1 performs neurexin-dependent and neurexin-independent functions in synapse validation. Embo J 28 32443255 .
  51. 51. KoJ.FuccilloM. V.MalenkaR. C.SudhofT. C. 2009 LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 64 791798 .
  52. 52. al. 2002 SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297 15251531 .
  53. 53. BiedererT.Stagi 2008 (2008) Signaling by synaptogenic molecules. Curr Opin Neurobiol 18 261269 .
  54. 54. FogelA. I.AkinsM. R.KruppA. al. 2007 SynCAMs organize synapses through heterophilic adhesion. J Neurosci 27 1251612530 .
  55. 55. RobbinsE. M.KruppA. J.Perez deArce. K.GhoshA. K.FogelA. al. 2010 SynCAM 1 adhesion dynamically regulates synapse number and impacts plasticity and learning. Neuron 68 894906 .
  56. 56. LeddaF.ParatchaG.Sandoval-GuzmanT.IbanezC. F. 2007 GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat Neurosci 10 293300 .
  57. 57. Ledda 2007 (2007) Ligand-induced cell adhesion as a new mechanism to promote synapse formation. Cell Adh Migr 1 137139 .
  58. 58. WangC. Y.YangF.HeX. P.JeH. S.ZhouJ. al. 2002 Regulation of neuromuscular synapse development by glial cell line-derived neurotrophic factor and neurturin. J Biol Chem 277 1061410625 .
  59. 59. ParatchaG.Ledda 2008 (2008) GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci 31 384391 .
  60. 60. ParatchaG.LeddaF.IbanezC. F. 2003 The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113 867879 .
  61. 61. UemuraT.LeeS. al. 2010 Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 141 10681079 .
  62. 62. al. 2010 Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science 328 363368 .
  63. 63. al. 2005 Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci 8 15341541 .
  64. 64. YasumuraM.YoshidaT.LeeS. J.UemuraT.JooJ. al. 2012 Glutamate receptor delta1 induces preferentially inhibitory presynaptic differentiation of cortical neurons by interacting with neurexins through cerebellin precursor protein subtypes. J Neurochem.
  65. 65. DohertyP.CEMoolenaarAshton. S. V.MichalidesR. J.WalshF. S. 1992 The VASE exon downregulates the neurite growth-promoting activity of NCAM 140. Nature 356 791793 .
  66. 66. al. 2002 Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. J Cell Biol 157 521532 .
  67. 67. MSAiraksinenArumae. U.RauvalaH.Saarma 1999S, Arumae U, Rauvala H, Saarma M (1999) [Neurotrophic growth factors in the development and plasticity of nervous system]. Duodecim 115 595605 .
  68. 68. KokaiaZ.MSAiraksinenNanobashvili. al. 1999 GDNF family ligands and receptors are differentially regulated after brain insults in the rat. Eur J Neurosci 11 12021216 .
  69. 69. al. 2011 SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 147 16011614 .
  70. 70. NaurP.HansenK. B.ASKristensenDravid. S. 2007 Ionotropic glutamate-like receptor delta2 binds D-serine and glycine. Proc Natl Acad Sci U S A 104 1411614121 .
  71. 71. HennebergerC.PapouinT.OlietS. H.RusakovD. A. 2010 Long-term potentiation depends on release of D-serine from astrocytes. Nature 463 232236 .
  72. 72. Sudhof TC 2008 Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455 903911 .
  73. 73. BetancurC.SakuraiT.JDBuxbaum 2009 The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 32 402412 .
  74. 74. al. 2006 High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 409 1013 .
  75. 75. KimH. G.KishikawaS.HigginsA. W.SeongI. S.DonovanD. al. 2008 Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82 199207 .
  76. 76. SzatmariP.PatersonA. al. 2007 Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39 319328 .
  77. 77. al. 2008 Neurexin 1alpha structural variants associated with autism. Neurosci Lett 438 368370 .
  78. 78. ZahirF. R.BarossA.DelaneyA. D.EydouxP.FernandesN. al. 2008 A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. J Med Genet 45 239243 .
  79. 79. MarshallC. R.NoorA.VincentJ. B.LionelA. al. 2008 Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82 477488 .
  80. 80. al. 2003 Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34 2729 .
  81. 81. al. 2004 X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74 552557 .
  82. 82. al. 2005 Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 10 329332 .
  83. 83. TalebizadehZ.LamD. Y.TheodoroM. F.BittelD. C.LushingtonG. al. 2006 Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 43: e21.
  84. 84. ChocholskaS.RossierE.BarbiG.Kehrer-Sawatzki 2006 (2006) Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. Am J Med Genet A 140 604610 .
  85. 85. Lawson-YuenA.SaldivarJ. S.SommerS.Picker 2008S, Sommer S, Picker J (2008) Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 16 614618 .
  86. 86. MacarovM.ZeiglerM.NewmanJ. al. 2007 Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. J Intellect Disabil Res 51 329333 .
  87. 87. al. 2008 Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 17 458465 .
  88. 88. WalshT.Mc ClellanJ. M.Mc CarthyS. E.AddingtonA. M.PierceS. al. 2008 Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 539543 .
  89. 89. TabuchiK.BlundellJ.EthertonM. R.HammerR. al. 2007 A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318 7176 .
  90. 90. al. 2008 Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A 105 17101715 .
  91. 91. al. 2008 Mutations in the gene encoding CADM1 are associated with autism spectrum disorder. Biochem Biophys Res Commun 377 926929 .
  92. 92. 2007 LRRTM1 on chromosome 212 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry 12: 1129-1139, 1057.
  93. 93. MDFallinLasseter. V. K.AvramopoulosD.NicodemusK. K.WolyniecP. al. 2005 Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77 918936 .

Written By

Fernanda Ledda

Published: 10 October 2012